ID   AHH-1 TK+/- h1A1v2
AC   CVCL_E7AJ
SY   h1A1v2
RX   PubMed=7923587;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct containing two copies of CYP1A1 (PubMed=7923587).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06988; Escherichia coli hisD.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UU61 ! AHH-1 TK+/-
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=7923587; DOI=10.1093/carcin/15.9.1931;
RA   Penman B.W., Chen L.-P., Gelboin H.V., Gonzalez F.J., Crespi C.L.;
RT   "Development of a human lymphoblastoid cell line constitutively
RT   expressing human CYP1A1 cDNA: substrate specificity with model
RT   substrates and promutagens.";
RL   Carcinogenesis 15:1931-1937(1994).
//